Initiator Pharma Gets UK CTA Approval For Phase 2a Study

About this update from Initiator Pharma A/s

Initiator Pharma A/S OMXSTO:INIT:RECEIVES UK CTA APPROVAL TO INITIATE PHASE 2A STUDY IN VULVODYNIAFIRST PATIENTS EXPECTED TO BE ENROLLED IN Q4 2025

View stock analysis, news, and events for Initiator Pharma A/s